Ipravent Respirator Solution
Ipratropium Bromide Respirator Solution
COMPOSITION
Each actuation delivers:
IPRAVENT Respirator Solution
Each ml contains:
Ipratropium Bromide BP … 250 mcg
- It is a bronchodilator, ( quaternary ammonium compound )
- The bronchodilation following inhalation of ipratropium bromide is induced by local
drug concentrations at the bronchial smooth muscle and not by systemic.
Indications
- For treatment of reversible bronchospasm associated with chronic obstructive
pulmonary disease (COPD).
- For treatment of reversible airways obstruction as in acute and chronic asthma.
Dosage and Administration
- The unit dose vials are intended only for inhalation with suitable nebulising devices
Should not be taken orally or administered parenterally.
- The recommended dose of Ipravent respirator solution is to be diluted with
physiological saline to a final volume of 3-4 m.
- Nebulised and inhaled until the solution is consumed.
|
